<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:blogger='http://schemas.google.com/blogger/2008' xmlns:georss='http://www.georss.org/georss' xmlns:gd="http://schemas.google.com/g/2005" xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-6577262713772599183</id><updated>2025-09-29T18:05:16.063+05:30</updated><category term="Clinical Research"/><category term="Analytical Method Development"/><category term="Research and Development"/><category term="Pharma Books"/><category term="Formulation and Development"/><category term="HPLC Doctor"/><category term="GLP"/><category term="LPO"/><category term="Process Validation"/><category term="KPO"/><title type='text'>Research and Development</title><subtitle type='html'>R&amp;amp;D is creative work undertaken on a systematic basis in order to increase the stock of knowledge, including knowledge of man, culture and society thus in R&amp;amp;D investigative activities that a business chooses to conduct with the intention of making a discovery that can either lead to the development of new products or procedures, or to improvement of existing products or procedures.</subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://pharmaresearchdevelopment.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default?redirect=false'/><link rel='alternate' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><link rel='next' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default?start-index=26&amp;max-results=25&amp;redirect=false'/><author><name>Research and Development</name><uri>http://www.blogger.com/profile/17948129999817246319</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>82</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-6577262713772599183.post-3001458355144111745</id><published>2011-01-03T16:46:00.000+05:30</published><updated>2011-01-03T16:46:25.722+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Research and Development"/><title type='text'>Inserting Sample on NMR Magnet</title><summary type="text">Inserting&amp;nbsp;Sample &amp;nbsp;1. NMR&amp;nbsp;tube&amp;nbsp;containing&amp;nbsp;sample&amp;nbsp;should&amp;nbsp;be&amp;nbsp;held&amp;nbsp;in&amp;nbsp;a&amp;nbsp;plastic&amp;nbsp;spinner&amp;nbsp;(use&amp;nbsp;the&amp;nbsp;blue&amp;nbsp;color&amp;nbsp;spinner&amp;nbsp;in&amp;nbsp;500&amp;nbsp;and&amp;nbsp;600&amp;nbsp;MHz&amp;nbsp;spectrometers;&amp;nbsp;use&amp;nbsp;the&amp;nbsp;white&amp;nbsp;color&amp;nbsp;spinner&amp;nbsp;in&amp;nbsp;700&amp;nbsp;MHz&amp;nbsp;spectrometer).&amp;nbsp;&amp;nbsp;Hold&amp;nbsp;the&amp;nbsp;sample&amp;</summary><link rel='replies' type='application/atom+xml' href='http://pharmaresearchdevelopment.blogspot.com/feeds/3001458355144111745/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2011/01/inserting-sample-on-nmr-magnet.html#comment-form' title='2 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/3001458355144111745'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/3001458355144111745'/><link rel='alternate' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2011/01/inserting-sample-on-nmr-magnet.html' title='Inserting Sample on NMR Magnet'/><author><name>Research and Development</name><uri>http://www.blogger.com/profile/17948129999817246319</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgsda8YhWvts1NZ3idQzfl76jWTfWf9O-dYBaHhls7IYnYhyphenhyphen5P94lN8fH6yGXfpMqK7KTRgryY1z6Eb__cQ97aHXmyIb_U0cVSLXTgMJc-lU9l-oOUXna9BX0W8UU973S8BciyWUJhPAGka/s72-c/New+Picture+%25281%2529.bmp" height="72" width="72"/><thr:total>2</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6577262713772599183.post-30136670596337132</id><published>2011-01-03T16:33:00.000+05:30</published><updated>2011-01-03T16:33:02.078+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Research and Development"/><title type='text'>Preparation of NMR Buffers Protocol</title><summary type="text">3. Preparation of NMR Buffers Protocol:3.1.Stock Solutions: 3.1.1 &amp;nbsp;0.1M stock solution of Na2HPO4. &amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Weigh 141.96g of Na2HPO4 (anhydrous) and dissolve to 1000 ml (one Liter) &amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;with ddH2O.3.1.2 &amp;nbsp;0.1M stock solution of NaH2PO4. &amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; Weigh 119.98g of NaH2PO4 (anhydrous) </summary><link rel='replies' type='application/atom+xml' href='http://pharmaresearchdevelopment.blogspot.com/feeds/30136670596337132/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2011/01/preparation-of-nmr-buffers-protocol.html#comment-form' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/30136670596337132'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/30136670596337132'/><link rel='alternate' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2011/01/preparation-of-nmr-buffers-protocol.html' title='Preparation of NMR Buffers Protocol'/><author><name>Research and Development</name><uri>http://www.blogger.com/profile/17948129999817246319</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6577262713772599183.post-6193589087336830025</id><published>2010-12-29T13:44:00.002+05:30</published><updated>2010-12-29T13:44:57.596+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Clinical Research"/><title type='text'>Clinical Trial in Nut Shell</title><summary type="text"></summary><link rel='replies' type='application/atom+xml' href='http://pharmaresearchdevelopment.blogspot.com/feeds/6193589087336830025/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/clinical-trial-in-nut-shell.html#comment-form' title='3 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/6193589087336830025'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/6193589087336830025'/><link rel='alternate' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/clinical-trial-in-nut-shell.html' title='Clinical Trial in Nut Shell'/><author><name>Research and Development</name><uri>http://www.blogger.com/profile/17948129999817246319</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgO3bkGXYQDbGnFVtFMpfxreLmDcWxMqIbm9_ANO7YKvEvlOz3zTj-SAQei2RzYB7A-BcBhmNKjFeKHTJlIjBCCjOsXkCcUZdILSl22v-LoJRvx6h_S_ApFrhsB4TfR-4otLOfp0_MZM00b/s72-c/Clin-Trials-Diagram-how-it-works.jpg" height="72" width="72"/><thr:total>3</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6577262713772599183.post-7541172911685567037</id><published>2010-12-29T12:39:00.003+05:30</published><updated>2010-12-29T12:59:19.850+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Clinical Research"/><title type='text'>Screening and Recruitment of Study Subjects in Clinical Research</title><summary type="text">Screening and Recruitment of Study Subjects




It is important that the Investigator resolves all questions from his/her staff concerning the interpretation of inclusion/exclusion criteria.The Investigator should be able to dedicate time to the recruitment of suitable trial subjects – the consultation time for recruitment of each subject is likely to be longer than the time required for normal </summary><link rel='replies' type='application/atom+xml' href='http://pharmaresearchdevelopment.blogspot.com/feeds/7541172911685567037/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/screening-and-recruitment-of-study.html#comment-form' title='5 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/7541172911685567037'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/7541172911685567037'/><link rel='alternate' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/screening-and-recruitment-of-study.html' title='Screening and Recruitment of Study Subjects in Clinical Research'/><author><name>Research and Development</name><uri>http://www.blogger.com/profile/17948129999817246319</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiNjCl1h3jf6urLF_8RSl3VV8CvCaCBKfBDDQgnMUJgOpEvJwy5hscFBKLiI5cxcCo5-Zr_1ojAoC5wHCZGdODufmX7gTV4rzCHVMwrWwOvIaAbNgPrjcgpit9eQvTOK3T15oSGjodss295/s72-c/iStock_000001535790XSmall.jpg" height="72" width="72"/><thr:total>5</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6577262713772599183.post-2491175882368040308</id><published>2010-12-29T12:32:00.002+05:30</published><updated>2010-12-29T12:32:25.238+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Clinical Research"/><title type='text'>Study Subjects Data and Documents For Clinical Research</title><summary type="text">Study Subjects Data and Documents For Clinical Research
&lt;!--[if !supportLists]--&gt;Ø&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;!--[endif]--&gt;All signed and dated informed consent forms (for enrolled and screened subjects).&lt;!--[if !supportLists]--&gt;Ø&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;!--[endif]--&gt;Study subject screening and/or enrolment log.&lt;!-</summary><link rel='replies' type='application/atom+xml' href='http://pharmaresearchdevelopment.blogspot.com/feeds/2491175882368040308/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/study-subjects-data-and-documents-for.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/2491175882368040308'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/2491175882368040308'/><link rel='alternate' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/study-subjects-data-and-documents-for.html' title='Study Subjects Data and Documents For Clinical Research'/><author><name>Research and Development</name><uri>http://www.blogger.com/profile/17948129999817246319</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6577262713772599183.post-6851379942980455756</id><published>2010-12-29T12:27:00.000+05:30</published><updated>2010-12-29T12:27:02.001+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Clinical Research"/><title type='text'>During the clinical research studies</title><summary type="text">

The trial can be initiated (begin screening and/or enrolment of trial subjects) only after the Clinical Monitor has satisfactorily conducted a Trial Initiation Monitoring Visit and the TDR Clinical Coordinator has given written authorization. 
Investigator’s File, Including Storage and RetentionOn initiation of the study, the Investigator must prepare a file containing documents related to the </summary><link rel='replies' type='application/atom+xml' href='http://pharmaresearchdevelopment.blogspot.com/feeds/6851379942980455756/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/during-clinical-research-studies.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/6851379942980455756'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/6851379942980455756'/><link rel='alternate' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/during-clinical-research-studies.html' title='During the clinical research studies'/><author><name>Research and Development</name><uri>http://www.blogger.com/profile/17948129999817246319</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjNRlalYrU5SyTwRsXM9S0K3phwat2GXUfu_qVHZDbgK4x4EnVfpIUq3Zl6lqiqls-kkaVHS6i6VQMgD76Q5t_CkFgkH8OFBSUKZuJIyDjJV8P7pwtHK8AVtfE1q4IC6Rbj1lGlXQ3zJonp/s72-c/clinical-research-inset.jpg" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6577262713772599183.post-105416204104862749</id><published>2010-12-29T11:56:00.001+05:30</published><updated>2010-12-29T12:30:22.456+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Research and Development"/><title type='text'>Probe Tuning :NMR</title><summary type="text">Probe Tuning :NMR


Probe tuning must be matched to the sample in order to minimize pulse widths and maximize sensitivity.&amp;nbsp; Although the effects are small for routine proton spectra, they can be dramatic for more complex pulse sequences.&amp;nbsp; Although the tuning changes between different organic solvents usually do not justify the effort to tune, if you are changing from an organic solvent </summary><link rel='replies' type='application/atom+xml' href='http://pharmaresearchdevelopment.blogspot.com/feeds/105416204104862749/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/probe-tuning-nmr.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/105416204104862749'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/105416204104862749'/><link rel='alternate' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/probe-tuning-nmr.html' title='Probe Tuning :NMR'/><author><name>Research and Development</name><uri>http://www.blogger.com/profile/17948129999817246319</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEix71avjZTNomYDKijiklbdBEJF24gHKUnnUxigFxqu_OoZFuWFded4L0OTfS0wItUTVvAX0oWvQfWEkML_Df5IQZL2priq1X4_gjn_xWnmCbBak2TdgVetVHxwwsFj50cb7yW_V3WciHHo/s72-c/New+Picture+%25286%2529.png" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6577262713772599183.post-3969910055963235442</id><published>2010-12-25T16:43:00.003+05:30</published><updated>2010-12-25T16:47:34.435+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Clinical Research"/><title type='text'>Prepare the required documents to be submitted to the IEC/IRB: according to ICH</title><summary type="text">Prepare the required documents to be submitted to the IEC/IRB:
Documents usually required by Ethics Committees·&amp;nbsp;&amp;nbsp; Investigator Brochure and up-to-date safety information.·&amp;nbsp;&amp;nbsp; Trial protocol (final version and amendments).·&amp;nbsp;&amp;nbsp; Consent form(s) and subject information sheets.·&amp;nbsp;&amp;nbsp; Subject recruitment procedures (e.g. advertisement·&amp;nbsp;&amp;nbsp; Information on </summary><link rel='replies' type='application/atom+xml' href='http://pharmaresearchdevelopment.blogspot.com/feeds/3969910055963235442/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/prepare-required-documents-to-be.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/3969910055963235442'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/3969910055963235442'/><link rel='alternate' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/prepare-required-documents-to-be.html' title='Prepare the required documents to be submitted to the IEC/IRB: according to ICH'/><author><name>Research and Development</name><uri>http://www.blogger.com/profile/17948129999817246319</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6577262713772599183.post-8243057353607521820</id><published>2010-12-25T16:41:00.002+05:30</published><updated>2010-12-25T16:41:44.169+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Clinical Research"/><title type='text'>Make sure that the local ethics committee fulfils the ICH GCP requirements. ICH GCP Composition and Operations of IEC/IRB</title><summary type="text">Make sure that the local ethics committee fulfils the ICH GCP requirements.ICH GCP Composition and Operations of IEC/IRB
&amp;nbsp;&amp;nbsp; The IRB/IEC should determine the authority under which it is established and the&amp;nbsp; composition (names and qualifications)of its members, which should consist of:&lt;!--[if !supportLists]--&gt;Ø&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;!--[endif]--&gt;A reasonable number of </summary><link rel='replies' type='application/atom+xml' href='http://pharmaresearchdevelopment.blogspot.com/feeds/8243057353607521820/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/make-sure-that-local-ethics-committee.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/8243057353607521820'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/8243057353607521820'/><link rel='alternate' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/make-sure-that-local-ethics-committee.html' title='Make sure that the local ethics committee fulfils the ICH GCP requirements. ICH GCP Composition and Operations of IEC/IRB'/><author><name>Research and Development</name><uri>http://www.blogger.com/profile/17948129999817246319</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6577262713772599183.post-8683209640750576102</id><published>2010-12-25T16:39:00.001+05:30</published><updated>2010-12-25T16:55:15.190+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Clinical Research"/><title type='text'>PRIOR TO INITIATION OF THE CLINICAL RESEARCH STUDY</title><summary type="text">PRIOR TO INITIATION OF THE CLINICAL RESEARCH STUDYThe Investigator should:Be interested in the scientific aspects of the study and ensure that the study is responsive to the needs of public health within the country of the population in which it will be conducted.
Ensure the confidentiality of the product, the protocol and trial procedures by giving a confidentiality agreement in writing to TDP/</summary><link rel='replies' type='application/atom+xml' href='http://pharmaresearchdevelopment.blogspot.com/feeds/8683209640750576102/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/prior-to-initiation-of-study.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/8683209640750576102'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/8683209640750576102'/><link rel='alternate' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/prior-to-initiation-of-study.html' title='PRIOR TO INITIATION OF THE CLINICAL RESEARCH STUDY'/><author><name>Research and Development</name><uri>http://www.blogger.com/profile/17948129999817246319</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6577262713772599183.post-8579320606141325834</id><published>2010-12-25T11:15:00.001+05:30</published><updated>2010-12-25T11:18:58.790+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Research and Development"/><title type='text'>Operating procedure for NMR spectrometer : Bruker Avance DPX-300  NMR spectrometer</title><summary type="text">
Note: 
Unless otherwise specified, statements such as “click on calib” mean to move the cursor on top of the calib button on the screen, and click with the left-hand mouse button. Consider the left-hand mouse button the default; if another button is required, it will be explicitly stated.&amp;nbsp; 
Commands such as “Enter zg” mean to type zg followed by a return on thekeyboard. Commands must be </summary><link rel='replies' type='application/atom+xml' href='http://pharmaresearchdevelopment.blogspot.com/feeds/8579320606141325834/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/operating-procedure-for-nmr.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/8579320606141325834'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/8579320606141325834'/><link rel='alternate' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/operating-procedure-for-nmr.html' title='Operating procedure for NMR spectrometer : Bruker Avance DPX-300  NMR spectrometer'/><author><name>Research and Development</name><uri>http://www.blogger.com/profile/17948129999817246319</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgKvgr303Yz9xjlN-lEKm1_yU4VQTQY3TxovlTR8H5iZ_Ahh1JuSo_4917JlZqiIePefuRv2ZBM_f6HzAAu8RM9rw-VF-d75-w7Tb8aAI_-tyAPwMFwSHDsUd3VjfFV2k6mPyqUCt40f-Qh/s72-c/nmr300.jpg" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6577262713772599183.post-3076917374917201205</id><published>2010-12-24T15:39:00.000+05:30</published><updated>2010-12-24T15:39:28.474+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Clinical Research"/><title type='text'>(ICH definition – International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use)</title><summary type="text">(ICH definition – International Conference on Harmonisation of technical requirements&amp;nbsp;for registration of pharmaceuticals for human use)



Adverse Drug Reaction (ADR)  In the pre-approval clinical experience with a new medicinal product or a product’ s new usages, particularly as the therapeutic dose(s) may not be established: all noxious and unintended responses to a medicinal product </summary><link rel='replies' type='application/atom+xml' href='http://pharmaresearchdevelopment.blogspot.com/feeds/3076917374917201205/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/ich-definition-international-conference.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/3076917374917201205'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/3076917374917201205'/><link rel='alternate' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/ich-definition-international-conference.html' title='(ICH definition – International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use)'/><author><name>Research and Development</name><uri>http://www.blogger.com/profile/17948129999817246319</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6577262713772599183.post-8838789694347019531</id><published>2010-12-24T15:18:00.000+05:30</published><updated>2010-12-24T15:18:54.450+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Clinical Research"/><title type='text'>Reconciliation of the Serious Adverse  Events</title><summary type="text">Reconciliation of the Serious Adverse &amp;nbsp;Events



Requirement:  
3.1 Reconciliation of SAEs captured during the conduct of clinical research trials and SAEs recorded in the Safety Database will occur several times during the lifecycle (the conduct) of the clinical research trial.&amp;nbsp; 3.2 Timing and number of the reconciliation cycles will be determined by the frequency of data received, the</summary><link rel='replies' type='application/atom+xml' href='http://pharmaresearchdevelopment.blogspot.com/feeds/8838789694347019531/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/reconciliation-of-serious-adverse.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/8838789694347019531'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/8838789694347019531'/><link rel='alternate' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/reconciliation-of-serious-adverse.html' title='Reconciliation of the Serious Adverse  Events'/><author><name>Research and Development</name><uri>http://www.blogger.com/profile/17948129999817246319</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6577262713772599183.post-1461005384280205918</id><published>2010-12-24T15:09:00.000+05:30</published><updated>2010-12-24T15:09:09.065+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Clinical Research"/><title type='text'>Conduct of Clinical Research study</title><summary type="text">Conduct of Clinical Research study



      Role       Responsibility  
      Study Coordinator       Maintain   and update the study plan for managing clinical data collected in accordance   with protocol specifications and/or requirements. Receive   data and log receipt of CRFs in a timely and appropriate manner. Transfer   or hand-over received CRFs to the relevant entry personnel for </summary><link rel='replies' type='application/atom+xml' href='http://pharmaresearchdevelopment.blogspot.com/feeds/1461005384280205918/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/conduct-of-clinical-research-study.html#comment-form' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/1461005384280205918'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/1461005384280205918'/><link rel='alternate' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/conduct-of-clinical-research-study.html' title='Conduct of Clinical Research study'/><author><name>Research and Development</name><uri>http://www.blogger.com/profile/17948129999817246319</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6577262713772599183.post-7152189155339458857</id><published>2010-12-21T15:34:00.000+05:30</published><updated>2010-12-21T15:34:00.683+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="HPLC Doctor"/><title type='text'>Base line drift, Base line noise, Broad peaks, Change in height, Negative peaks, Ghost peaks in HPLC</title><summary type="text">Base line drift



&amp;nbsp;What You Expect &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; What You Got




      Disease      Medicine  
      Fluctuation of column   temperature      Stabilize. Use column oven  
      Contamination of mobile phase/</summary><link rel='replies' type='application/atom+xml' href='http://pharmaresearchdevelopment.blogspot.com/feeds/7152189155339458857/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/base-line-drift-base-line-noise-broad.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/7152189155339458857'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/7152189155339458857'/><link rel='alternate' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/base-line-drift-base-line-noise-broad.html' title='Base line drift, Base line noise, Broad peaks, Change in height, Negative peaks, Ghost peaks in HPLC'/><author><name>Research and Development</name><uri>http://www.blogger.com/profile/17948129999817246319</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjIWuAcjhNbn0qyeAG82wrfzL8b83ZPQo-wsre4mt51kw3cM_IwDHvk4RVHRoev_nnhfVYPJYIisiT7wq0h7XrKUwCNATjXnhWC6Ihcxfb5tScUJslLs8MKPbBloIdD_4-6PH1BRKlZJWzN/s72-c/New+Picture.png" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6577262713772599183.post-1868575027469230847</id><published>2010-12-20T16:07:00.000+05:30</published><updated>2010-12-20T16:07:57.409+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="HPLC Doctor"/><title type='text'>Peak tailing, Peak Fronting, Rounded Peaks in HPLC chromatogram</title><summary type="text">Peak tailing



What you expect &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; What you Got




      Disease      Medicine  
      Active sites within the column      Test with standard test mixture. If OK add   competing base or acid modifier  
      Wrong pH      Correct  
      Wrong column      Change  
      Void volume</summary><link rel='replies' type='application/atom+xml' href='http://pharmaresearchdevelopment.blogspot.com/feeds/1868575027469230847/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/peak-tailing-peak-fronting-rounded.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/1868575027469230847'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/1868575027469230847'/><link rel='alternate' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/peak-tailing-peak-fronting-rounded.html' title='Peak tailing, Peak Fronting, Rounded Peaks in HPLC chromatogram'/><author><name>Research and Development</name><uri>http://www.blogger.com/profile/17948129999817246319</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg9cqvtCa4ejV7PFSqdsF75jKDz0D_pvEflUwHhax05nnkMbZTxpMl4IpYYkM9BWc2c4oJBx1bG-1Xmg9THvZUTDfgRsCGhPVZ54EMjGsRTbobLiHKUtiaW4n5SRvlERrutR-E_j1CQeJXD/s72-c/New+Picture+%252821%2529.png" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6577262713772599183.post-1913149454963792995</id><published>2010-12-20T15:53:00.000+05:30</published><updated>2010-12-20T15:53:15.613+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="HPLC Doctor"/><title type='text'>Peak splitting</title><summary type="text">Peak splitting



What you Expect &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; What you Got






      Disease      Medicine  
      Contamination of column or guard      Remove guard column. If the problem is solved   replace it. If not go next  
      Plugged column      Use adequate recovery procedure. If the problem   </summary><link rel='replies' type='application/atom+xml' href='http://pharmaresearchdevelopment.blogspot.com/feeds/1913149454963792995/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/peak-splitting.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/1913149454963792995'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/1913149454963792995'/><link rel='alternate' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/peak-splitting.html' title='Peak splitting'/><author><name>Research and Development</name><uri>http://www.blogger.com/profile/17948129999817246319</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhJ9V2AGQ_p5a60rPPRe2vy2wjd9ItNg5d3l5bEhhA77RDQETFaODW_7WVQKE2EpMJ0DaaTgeMJleyFcRJSLhtXGCMi4rbWIjqNq-UE2QqGCeXtFXIlAys3BmKk6K2w7nfO6OFNfrGwSxvl/s72-c/New+Picture+%252819%2529.png" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6577262713772599183.post-4203826792008946476</id><published>2010-12-20T15:19:00.000+05:30</published><updated>2010-12-20T15:19:13.616+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="HPLC Doctor"/><title type='text'>Retention times are not constant</title><summary type="text">Retention times are not constant



What you Expect &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; What you Got &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;&amp;nbsp;

      Disease      Medicine  
      Leak      Check for loose fittings
</summary><link rel='replies' type='application/atom+xml' href='http://pharmaresearchdevelopment.blogspot.com/feeds/4203826792008946476/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/retention-times-are-not-constant.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/4203826792008946476'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/4203826792008946476'/><link rel='alternate' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/retention-times-are-not-constant.html' title='Retention times are not constant'/><author><name>Research and Development</name><uri>http://www.blogger.com/profile/17948129999817246319</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhFGO37jRQKjUdPRBj37G3s54xXeddkl8kEEb-y8QKfEiCzUnRtsh418yIaAd21sQ14nJgaquBfIEQF3ZxhDhKmO_wxTDIE8eqMHRnfB7wKl1EC9-ruqkDT2yVSAzwjCwJrwbP4aB_ncrQ8/s72-c/New+Picture+%252817%2529.png" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6577262713772599183.post-1502821086506910284</id><published>2010-12-20T15:03:00.000+05:30</published><updated>2010-12-20T15:03:34.832+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="HPLC Doctor"/><title type='text'>No Pressure or Pressure Lower than anticipated</title><summary type="text">No Pressure or Pressure Lower than&amp;nbsp;anticipated


&amp;nbsp;&amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp;&amp;nbsp;What you Expect. &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; &amp;nbsp; What you got






      Disease      Medicine  
      Leak      Check for loose   fittings
Check pump for leaks, salts and noise
Check</summary><link rel='replies' type='application/atom+xml' href='http://pharmaresearchdevelopment.blogspot.com/feeds/1502821086506910284/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/no-pressure-or-pressure-lower-than.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/1502821086506910284'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/1502821086506910284'/><link rel='alternate' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/no-pressure-or-pressure-lower-than.html' title='No Pressure or Pressure Lower than anticipated'/><author><name>Research and Development</name><uri>http://www.blogger.com/profile/17948129999817246319</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgM5sT9k9bxpdVWhXyMQRSgSbQq9q081itx6LxpDAlmiHvNQgN9FYkzhVbPThKIusYWPThQMVKMjlxsRLYxvjGeMR6WK2hyphenhyphenwkYPutasHsbxTXYofWpiz6dLIMKw-NpbR9s3IlcOHce9PIQP/s72-c/New+Picture+%252814%2529.png" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6577262713772599183.post-709252502400394612</id><published>2010-12-20T12:34:00.000+05:30</published><updated>2010-12-20T12:34:36.984+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="HPLC Doctor"/><title type='text'>No Peaks or view Small Peaks in HPLC</title><summary type="text">No Peaks or view Small Peaks in HPLC
What You Expect&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; What You got

&lt;!--[if gte mso 9]&gt;     Normal   0         false   false   false                             MicrosoftInternetExplorer4   </summary><link rel='replies' type='application/atom+xml' href='http://pharmaresearchdevelopment.blogspot.com/feeds/709252502400394612/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/no-peaks-or-view-small-peaks-in-hplc.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/709252502400394612'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/709252502400394612'/><link rel='alternate' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/no-peaks-or-view-small-peaks-in-hplc.html' title='No Peaks or view Small Peaks in HPLC'/><author><name>Research and Development</name><uri>http://www.blogger.com/profile/17948129999817246319</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj1pnDgkty-LX-OIljuwd3IBiGkLPKCVajSFNKG1Sv7xDtnEn2gBng777bJpknn3AmjxmZGuYCVWyqKhtXPqsJpQ-v8cbevpMf0aU4wNs7RMrQOirRQ50AgIZi2vU0_vM1ykebynikMQgfo/s72-c/New+Picture+%25281%2529.png" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6577262713772599183.post-1559111092989436891</id><published>2010-12-20T11:19:00.001+05:30</published><updated>2010-12-20T11:39:29.912+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Analytical Method Development"/><title type='text'>Operating Procedure of BRUKER AUTOFLEX MALDI-TOF Mass Spectrometer</title><summary type="text">Operating Procedure of BRUKER AUTOFLEX MALDI-TOF Mass Spectrometer

&amp;nbsp; 

&amp;nbsp;&amp;nbsp;&amp;nbsp; 1.&amp;nbsp; Press Ctrl-Alt-Del and enter your name and password to log into the computer. Allow 
&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; time (30-60 s) for background processes to start. 

&amp;nbsp;&amp;nbsp;&amp;nbsp; 2.&amp;nbsp; Exit the WinTV application by clicking a cross in the right top corner of the window.</summary><link rel='replies' type='application/atom+xml' href='http://pharmaresearchdevelopment.blogspot.com/feeds/1559111092989436891/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/operating-procedure-of-bruker-autoflex.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/1559111092989436891'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/1559111092989436891'/><link rel='alternate' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/operating-procedure-of-bruker-autoflex.html' title='Operating Procedure of BRUKER AUTOFLEX MALDI-TOF Mass Spectrometer'/><author><name>Research and Development</name><uri>http://www.blogger.com/profile/17948129999817246319</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgMDh6xHieQ316w975WjyW02uk6FqkfnD_iyNiu0G5eTPgt61XnHjETEHdATGlriQbj75Xwv-yUBeS4_BUhq9n1JUav-sPIZPWedVDXFoFMpUDrxxbj3JF0AFDqjtcfUwPBzdslWewgqq3W/s72-c/mass.jpg" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6577262713772599183.post-2652728657609453663</id><published>2010-12-18T17:20:00.000+05:30</published><updated>2010-12-18T17:20:17.500+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Analytical Method Development"/><title type='text'>Method Development in UHPLC</title><summary type="text">Method Development in UHPLC The rules for developing a new method in UHPLC are slightly different from those of conventional HPLC because it is necessary to account for the backpressure constraint generated by the use of small particles. 
3.1. Choice of column dimensions&amp;nbsp; Depending on the supplier, it is possible to find some columns dedicated to UHPLC with internal diameters of 1, 2.1 and </summary><link rel='replies' type='application/atom+xml' href='http://pharmaresearchdevelopment.blogspot.com/feeds/2652728657609453663/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/method-development-in-uhplc.html#comment-form' title='0 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/2652728657609453663'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/2652728657609453663'/><link rel='alternate' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/method-development-in-uhplc.html' title='Method Development in UHPLC'/><author><name>Research and Development</name><uri>http://www.blogger.com/profile/17948129999817246319</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjiYiQt96d8L3wpQ2RBSanjq7T3u0ar_XK1S6iJW-Xbinu-QL4IW_w0ThsLXJW9a-lxJvIIOSWsYzcWnaM8CXV23D9lawyh80c7Xj-6otgqq0SKzrphEu6f9NcwYuAY-ctktHmwDm5VF-nr/s72-c/tree.bmp" height="72" width="72"/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6577262713772599183.post-7314191474103390385</id><published>2010-12-18T16:54:00.000+05:30</published><updated>2010-12-18T16:54:29.963+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Analytical Method Development"/><title type='text'>HPLC: Analytical Method Vallidation</title><summary type="text">Method validation. Proper validation of analytical methods is important for pharmaceutical analysis when ensurance of the continuing efficacy and safety of each batch manufactured relies solely on the determination of quality. The ability to control this quality is dependent upon the ability of the analytical methods, as applied under well-defined conditions and at an established level of </summary><link rel='replies' type='application/atom+xml' href='http://pharmaresearchdevelopment.blogspot.com/feeds/7314191474103390385/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/hplc-analytical-method-vallidation.html#comment-form' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/7314191474103390385'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/7314191474103390385'/><link rel='alternate' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/hplc-analytical-method-vallidation.html' title='HPLC: Analytical Method Vallidation'/><author><name>Research and Development</name><uri>http://www.blogger.com/profile/17948129999817246319</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiB4b9dX81m6TusRuBaAFUNLPhzaWOQ2HDlGtyB9zFfh1EG5FoIlmdOjKoO42IySZkN8UxZbsSj2H23u-K51sI9OLz1eApUOSRhxjdnwaTOsbVqTn0TFp0edoK61sG9NFaVUgjUyUMrKj2q/s72-c/New+validation.png" height="72" width="72"/><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6577262713772599183.post-4567248973541941113</id><published>2010-12-18T15:06:00.000+05:30</published><updated>2010-12-18T15:06:56.329+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Analytical Method Development"/><title type='text'>Optimizing the Separation : HPLC</title><summary type="text">Optimizing the Separation



Once you have a separation you may want to optimize it.&amp;nbsp; You may wish to shallow out the gradient to improve the separation, or you may wish to shorten the run time.&amp;nbsp; Taking the illustration above one can see that all of the peptides are out by 40 minutes.&amp;nbsp; This does not mean that we can change this 80 min run into a 40 min run, but there is room for </summary><link rel='replies' type='application/atom+xml' href='http://pharmaresearchdevelopment.blogspot.com/feeds/4567248973541941113/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/optimizing-separation-hplc.html#comment-form' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/4567248973541941113'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/4567248973541941113'/><link rel='alternate' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/optimizing-separation-hplc.html' title='Optimizing the Separation : HPLC'/><author><name>Research and Development</name><uri>http://www.blogger.com/profile/17948129999817246319</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh6gMX_OBMEnQC-sd46wu8AFrChnK0erbTVqPNjK_rnMNmp189B3p8OgjIVkPvutblXAj-Mvov9pto7XI__T6IsRMWv7VLeA2-CNaMawgjELCnWCjrwC5TcKWS0XQCLIYLNxG_rwr38GO-k/s72-c/New+Picture+%252812%2529.png" height="72" width="72"/><thr:total>1</thr:total></entry><entry><id>tag:blogger.com,1999:blog-6577262713772599183.post-4308369598389374918</id><published>2010-12-18T15:02:00.000+05:30</published><updated>2010-12-18T15:02:08.893+05:30</updated><category scheme="http://www.blogger.com/atom/ns#" term="Analytical Method Development"/><title type='text'>HPLC: Tutorial</title><summary type="text">Introduction
The message of this tutorial is that reverse phase HPLC is simple.&amp;nbsp; Compounds stick to reverse phase HPLC columns in high aqueous mobile phase and are eluted from RP HPLC columns with&amp;nbsp; high organic mobile phase.&amp;nbsp; In RP HPLC compounds are separated based on their hydrophobic character.&amp;nbsp; Peptides can be separated by running a linear gradient of the organic solvent.&amp;</summary><link rel='replies' type='application/atom+xml' href='http://pharmaresearchdevelopment.blogspot.com/feeds/4308369598389374918/comments/default' title='Post Comments'/><link rel='replies' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/hplc-tutorial.html#comment-form' title='1 Comments'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/4308369598389374918'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/6577262713772599183/posts/default/4308369598389374918'/><link rel='alternate' type='text/html' href='http://pharmaresearchdevelopment.blogspot.com/2010/12/hplc-tutorial.html' title='HPLC: Tutorial'/><author><name>Research and Development</name><uri>http://www.blogger.com/profile/17948129999817246319</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='https://img1.blogblog.com/img/b16-rounded.gif'/></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhI7w8EOyfp5AaUFWdGutPbV7W1ZSrdSEpew7rRZjU4lzxKiDyvQNeOqjgzCJflU0YtA0kD1TH3pVn8hZKiSVdrQ6iNpVFXpst3CXGD-3OxNcIoKlzaB8MVo_8PgFyL8BzSwOcjYdCt8-o7/s72-c/New+Picture.png" height="72" width="72"/><thr:total>1</thr:total></entry></feed>